Sign In
Buy CORT
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Stock Upgrades: Corcept Therapeutics Shows Rising Relative Strength
12:00am, Wednesday, 26'th Feb 2020An Intrinsic Calculation For Corcept Therapeutics Incorporated (NASDAQ:CORT) Suggests It's 25% Undervalued
11:22am, Tuesday, 25'th Feb 2020
Today we will run through one way of estimating the intrinsic value of Corcept Therapeutics Incorporated (NASDAQ:CORT...
Crossmark Global Holdings Inc. Acquires 870 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)
09:30am, Tuesday, 25'th Feb 2020
Crossmark Global Holdings Inc. boosted its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 4.5% in the fourth quarter, according to the company in its most recent 13F filing with the Se
Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Corcept Therapeutics Incorporated (CORT)
05:41pm, Monday, 24'th Feb 2020
SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)---- $CORT #ClassAction--Shareholder rights law firm Robbins LLP is investigating the officers and directors of Corcept Therapeutics Incorporated (NASDAQ
Corcept Therapeutics Inc (CORT) Files –…-K for the Fiscal Year Ended on December '–, ...
12:00am, Monday, 24'th Feb 2020Acadian Asset Management LLC Has $2.11 Million Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)
09:08am, Sunday, 23'rd Feb 2020
Acadian Asset Management LLC lessened its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 16.3% in the fourth quarter, according to the company in its most recent 13F filing w
Corcept Therapeutics (NASDAQ:CORT) Releases Earnings Results, Hits Expectations
08:07pm, Friday, 21'st Feb 2020
Corcept Therapeutics (NASDAQ:CORT) released its quarterly earnings data on Thursday. The biotechnology company reported $0.24 earnings per share (EPS) for the quarter, meeting analysts’ consensus es
Corcept (CORT) Q4 Earnings In-Line with Estimates, Up Y/Y
07:25pm, Friday, 21'st Feb 2020
Corcept Therapeutics (CORT) reports in-line earnings in the fourth quarter of 2020.
Corcept (CORT) Q4 Earnings In-Line with Estimates, Up Y/Y
07:25pm, Friday, 21'st Feb 2020
Corcept Therapeutics (CORT) reports in-line earnings in the fourth quarter of 2020.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teleflex (TFX), Corcept Therapeutics (CORT) and PRA Health Sciences
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teleflex (
TFX
–
Research Report
), Corcept Therapeutics (
CORT
–
Research Report
) and PRA Health Sciences (
PRAH
State of New Jersey Common Pension Fund D Reduces Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)
02:46pm, Friday, 21'st Feb 2020
State of New Jersey Common Pension Fund D trimmed its position in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 38.1% during the 4th quarter, according to its most recent Form 13F filing with the
H.C. Wainwright Sticks to Its Buy Rating for Corcept Therapeutics (CORT)
12:10pm, Friday, 21'st Feb 2020
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Corcept Therapeutics (CORT) today and set a price target of $18.00. The
H.C. Wainwright Sticks to Its Buy Rating for Corcept Therapeutics (CORT)
12:10pm, Friday, 21'st Feb 2020
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Corcept Therapeutics (CORT – Research Report) today and set a
